Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T R Jeffry Evans

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
Tumori|October 28, 2009
Coexistent malignant melanoma and renal cell carcinomaBalaji Venugopal, T R Jeffry Evans
Advances in Therapy|October 31, 2008
Systemic therapy of hepatocellular carcinoma: are we making progress?Patricia Roxburgh, T R Jeffry Evans
Oncotargets and Therapy|December 4, 2010
The epidermal growth factor receptor family in breast cancerAngelos K Koutras, T R Jeffry Evans
F1000Research|September 17, 2016
Virotherapy: cancer gene therapy at last?Alan E Bilsland, Pavlina Spiliopoulou, T R Jeffry Evans
The Journal of Pathology|December 18, 2001
Telomerase and cancer: time to move from a promising target to a clinical realityW N Keith, T R Jeffry Evans, R M Glasspool
Nature Clinical Practice. Oncology|November 3, 2005
Drug insight: Cancer cell immortality-telomerase as a target for novel cancer gene therapiesW Nicol Keith, Alan Bilsland, Maryon Hardie, et al.
Expert Reviews in Molecular Medicine|February 28, 2004
Telomerase-directed molecular therapeuticsW Nicol Keith, Alan Bilsland, T R Jeffry Evans, et al.
Nature Reviews. Cancer|February 18, 2015
Mining the genomes of exceptional respondersDavid K Chang, Sean M Grimmond, T R Jeffry Evans, et al.
Critical Reviews in Oncology/Hematology|July 6, 2002
Cancer of the anal regionLisa Licitra, Silvia Spinazzé, Roberto Doci, et al.
Anticancer Research|June 17, 2009
Antitumor activity of a selectively replication competent herpes simplex virus (HSV) with enzyme prodrug therapyLynne Braidwood, Paul D Dunn, Susan Hardy, et al.
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
Tumori|October 28, 2009
Coexistent malignant melanoma and renal cell carcinomaBalaji Venugopal, T R Jeffry Evans
Advances in Therapy|October 31, 2008
Systemic therapy of hepatocellular carcinoma: are we making progress?Patricia Roxburgh, T R Jeffry Evans
Oncotargets and Therapy|December 4, 2010
The epidermal growth factor receptor family in breast cancerAngelos K Koutras, T R Jeffry Evans
F1000Research|September 17, 2016
Virotherapy: cancer gene therapy at last?Alan E Bilsland, Pavlina Spiliopoulou, T R Jeffry Evans
The Journal of Pathology|December 18, 2001
Telomerase and cancer: time to move from a promising target to a clinical realityW N Keith, T R Jeffry Evans, R M Glasspool
Nature Clinical Practice. Oncology|November 3, 2005
Drug insight: Cancer cell immortality-telomerase as a target for novel cancer gene therapiesW Nicol Keith, Alan Bilsland, Maryon Hardie, et al.
Expert Reviews in Molecular Medicine|February 28, 2004
Telomerase-directed molecular therapeuticsW Nicol Keith, Alan Bilsland, T R Jeffry Evans, et al.
Nature Reviews. Cancer|February 18, 2015
Mining the genomes of exceptional respondersDavid K Chang, Sean M Grimmond, T R Jeffry Evans, et al.
Critical Reviews in Oncology/Hematology|July 6, 2002
Cancer of the anal regionLisa Licitra, Silvia Spinazzé, Roberto Doci, et al.
Anticancer Research|June 17, 2009
Antitumor activity of a selectively replication competent herpes simplex virus (HSV) with enzyme prodrug therapyLynne Braidwood, Paul D Dunn, Susan Hardy, et al.
Pageof 6